Clinical and experimental advances in regeneration of spinal cord injury

Journal of Tissue Engineering

Volumn 1, Issue 1, 2010, Pages 1-20

  Hyun, Jung Keun ^a,b,c   Kim, Hae Won ^a,c,d  

^a Dankook University   (South Korea)

^b Dankook University College of Medicine   (South Korea)

^c BK21 Plus NBM Global Research Center for Regenerative Medicine   (South Korea)

^d Dankook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

SCAFFOLDS; SCAFFOLDS (BIOLOGY); STEM CELLS;

CELL TRANSPLANTATION; CLINICAL SETTINGS; CLINICAL TRIAL; IN-VIVO; MOTOR IMPAIRMENTS; PHARMACOLOGICAL TREATMENT; RECOVERY SPEED; SENSORY IMPAIRMENT; SPINAL CORD INJURY; SPINAL-CORD;

PATIENT REHABILITATION;

EID: 84887326195     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.4061/2010/650857     Document Type: Review

References (155)

1. M. Wyndaele and J.-J. Wyndaele, "Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey?" Spinal Cord, vol. 44, no. 9, pp. 523-529, 2006.
2. C. E. Hulsebosch, "Recent advances in pathophysiology and treatment of spinal cord injury," American Journal of Physiology, vol. 26, no. 1-4, pp. 238-255, 2002.
3. L. H. S. Sekhon and M. G. Fehlings, "Epidemiology, demographics, and pathophysiology of acute spinal cord injury," Spine, vol. 26, no. 24, pp. S2-S12, 2001.
4. E. D. Hall and J. E. Springer, "Neuroprotection and acute spinal cord injury: a reappraisal," NeuroRx, vol. 1, no. 1, pp. 80-100, 2004.
5. S. Thuret, L. D. F. Moon, and F. H. Gage, "Therapeutic interventions after spinal cord injury," Nature Reviews Neuroscience, vol. 7, no. 8, pp. 628-643, 2006.
6. M. B. Bracken, W. F. Collins, D. F. Freeman et al., "Efficacy of methylprednisolone in acute spinal cord injury," Journal of the American Medical Association, vol. 251, no. 1, pp. 45-52, 1984.
7. M. B. Bracken, M. J. Shepard, W. F. Collins et al., "A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study," The New England Journal of Medicine, vol. 322, no. 20, pp. 1405-1411, 1990.
8. M. B. Bracken, M. J. Shepard, T. R. Holford et al., "Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: results of the Third National Acute Spinal Cord Injury randomized controlled trial," Journal of the AmericanMedical Association, vol. 277, no. 20, pp. 1597-1604, 1997.
9. J. Xu, S. Chen, H. Chen et al., "STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes," Journal of Neuroscience, vol. 29, no. 7, pp. 2022-2026, 2009.
10. J.-M. Lee, P. Yan, Q. Xiao et al., "Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury," Journal of Neuroscience, vol. 28, no. 12, pp. 3141-3149, 2008.
11. P. J. Barnes, "Anti-inflammatory actions of glucocorticoids: molecular mechanisms," Clinical Science, vol. 94, no. 6, pp. 557-572, 1998.
12. M. B. Bracken, "Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial," Journal of Neurotrauma, vol. 8, no. 1, pp. S47-S50, 1991.
13. H.-C. Lee, D.-Y. Cho, W.-Y. Lee, and H.-C. Chuang, "Pitfalls in treatment of acute cervical spinal cord injury using highdose methylprednisolone: a retrospect audit of 111 patients," Surgical Neurology, vol. 68, supplement 1, pp. S37-S41, 2007.
14. F. T. Sayer, E. Kronvall, and O. G. Nilsson, "Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature," Spine Journal, vol. 6, no. 3, pp. 335-343, 2006.
15. S. M. Miller, "Methylprednisolone in acute spinal cord injury: a tarnished standard," Journal of Neurosurgical Anesthesiology, vol. 20, no. 2, pp. 140-142, 2008.
16. I. Rozet, "Methylprednisolone in acute spinal cord injury: is there any other ethical choice?" Journal of Neurosurgical Anesthesiology, vol. 20, no. 2, pp. 137-139, 2008.
17. R. J. Hurlbert and M. G. Hamilton, "Methylprednisolone for acute spinal cord injury: 5-year practice reversal," Canadian Journal of Neurological Sciences, vol. 35, no. 1, pp. 41-45, 2008.
18. F. H. Geisler, W. P. Coleman, G. Grieco, and D. Poonian, "The Sygen multicenter acute spinal cord injury study," Spine, vol. 26, no. 24, pp. S87-S100, 2001.
19. F. H. Geisler, F. C. Dorsey, and W. P. Coleman, "Recovery of motor function after spinal-cord injury-a randomized, placebo-controlled trial with GM-1 ganglioside," The New England Journal of Medicine, vol. 324, no. 26, pp. 1829-1838, 1991.
20. P. Chinnock and I. Roberts, "Gangliosides for acute spinal cord injury," Cochrane Database of Systematic Reviews, no. 2, Article ID CD004444, 2005.
21. B. A. Bryan, E. Dennstedt, D. C. Mitchell et al., "RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis," The FASEB Journal, vol. 24, no. 9, pp. 3186-3195, 2010.
22. D. C. Baptiste and M. G. Fehlings, "Pharmacological approaches to repair the injured spinal cord," Journal of Neurotrauma, vol. 23, no. 3-4, pp. 318-334, 2006.
23. D. C. Baptiste, A. Tighe, and M. G. Fehlings, "Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury," Expert Opinion on Investigational Drugs, vol. 18, no. 5, pp. 663-673, 2009.
24. G. Schwartz and M. G. Fehlings, "Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole," Journal of Neurosurgery, vol. 94, no. 2, pp. 245-256, 2001.
25. J. Killestein, N. F. Kalkers, and C. H. Polman, "Glutamate inhibition in MS: the neuroprotective properties of riluzole," Journal of the Neurological Sciences, vol. 233, no. 1-2, pp. 113-115, 2005.
26. V.W. Yong, J. Wells, F. Giuliani, S. Casha, C. Power, and L. M. Metz, "The promise of minocycline in neurology," The Lancet Neurology, vol. 3, no. 12, pp. 744-751, 2004.
27. Y. D. Teng, H. Choi, R. C. Onario et al., "Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 3071-3076, 2004.
28. S. M. Lee, T. Y. Yune, S. J. Kim et al., "Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat," Journal of Neurotrauma, vol. 20, no. 10, pp. 1017-1027, 2003.
29. A. Pinzon, A. Marcillo, A. Quintana et al., "A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model," Brain Research, vol. 1243, pp. 146-151, 2008.
30. M. Celik, N. Gökmen, S. Erbayraktar et al., "Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 4, pp. 2258-2263, 2002.
31. H. Ehrenreich, M. Hasselblatt, C. Dembowski et al., "Erythropoietin therapy for acute stroke is both safe and beneficial," Molecular Medicine, vol. 8, no. 8, pp. 495-505, 2002.
32. S. U. Yanpallewar, D. Hota, S. Rai, M. Kumar, and S. B. Acharya, "Nimodipine attenuates biochemical, behavioral and histopathological alterations induced by acute transient and long-term bilateral common carotid occlusion in rats," Pharmacological Research, vol. 49, no. 2, pp. 143-150, 2004.
33. T. Winkler, H. S. Sharma, E. Stålberg, R. D. Badgaiyan, T. Gordh, and J. Westman, "An L-type calcium channel blocker, nimodipine influences trauma induced spinal cord conduction and axonal injury in the rat," Acta neurochirurgica. Supplement, vol. 86, pp. 425-432, 2003.
34. V. Pointillart, M. Petitjean, L. Wiart et al., "Pharmacological therapy of spinal cord injury during the acute phase," Spinal Cord, vol. 38, no. 2, pp. 71-76, 2000.
35. F. Callera and R. X. do Nascimento, "Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study," Experimental Hematology, vol. 34, no. 2, pp. 130-131, 2006.
36. G. A. Moviglia, R. Fernandez Viña, J. A. Brizuela et al., "Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients," Cytotherapy, vol. 8, no. 3, pp. 202-209, 2006.
37. S. H. Yoon, Y. S. Shim, Y. H. Park et al., "Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial," Stem Cells, vol. 25, no. 8, pp. 2066-2073, 2007.
38. E. Syková, A. Homola, R. Mazanec et al., "Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury," Cell Transplantation, vol. 15, no. 8-9, pp. 675-687, 2006.
39. R. Pal, N. K. Venkataramana, A. Bansal et al., "Ex vivoexpanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study," Cytotherapy, vol. 11, no. 7, pp. 897-911, 2009.
40. A. A. Kumar, S. R. Kumar, R. Narayanan, K. Arul, and M. Baskaran, "Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I/II clinical safety and primary efficacy data," Experimental and Clinical Transplantation, vol. 7, no. 4, pp. 241-248, 2009.
41. E. R. Chernykh, V. V. Stupak, G. M. Muradov et al., "Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients," Bulletin of Experimental Biology and Medicine, vol. 143, no. 4, pp. 543-547, 2007.
42. H. Deda, M. C. Inci, AE. Kurekcç et al., "Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1- year follow-up," Cytotherapy, vol. 10, no. 6, pp. 565-574, 2008.
43. A. F. Cristante, T. E. P. Barros-Filho, N. Tatsui et al., "Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients," Spinal Cord, vol. 47, no. 10, pp. 733-738, 2009.
44. A. Mackay-Sim, F. Féron, J. Cochrane et al., "Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial," Brain, vol. 131, no. 9, pp. 2376-2386, 2008.
45. C. Lima, P. Escada, J. Pratas-Vital et al., "Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury," Neurorehabilitation and Neural Repair, vol. 24, no. 1, pp. 10-22, 2010.
46. H. S. Chhabra, C. Lima, S. Sachdeva et al., "Autologous mucosal transplant in chronic spinal cord injury: an Indian Pilot Study," Spinal Cord, vol. 47, no. 12, pp. 887-895, 2009.
47. H. Saberi, P. Moshayedi, H.-R. Aghayan et al., "Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes," Neuroscience Letters, vol. 443, no. 1, pp. 46-50, 2008.
48. N. Knoller, G. Auerbach, V. Fulga et al., "Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results," Journal of Neurosurgery Spine, vol. 3, no. 3, pp. 173-181, 2005.
49. D. Lammertse, M. H. Tuszynski, J. D. Steeves et al., "Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design," Spinal Cord, vol. 45, no. 3, pp. 232-242, 2007.
50. D. C. Hess and C. V. Borlongan, "Stem cells and neurological diseases," Cell Proliferation, vol. 41, no. 1, pp. 94-114, 2008.
51. M. Sasaki, C. Radtke, A. M. Tan et al., "BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury," Journal of Neuroscience, vol. 29, no. 47, pp. 14932-14941, 2009.
52. H.-J. Kim, J.-H. Lee, and S.-H. Kim, "Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis," Journal of Neurotrauma, vol. 27, no. 1, pp. 131-138, 2010.
53. W. Tetzlaff, E. B. Okon, S. Karimi-Abdolrezaee et al., "A systematic review of cellular transplantation therapies for spinal cord injury," Journal of Neurotrauma. In press.
54. Z. Lei, L. Yongda, M. Jun et al., "Culture and neural differentiation of rat bone marrow mesenchymal stem cells in vitro," Cell Biology International, vol. 31, no. 9, pp. 916-923, 2007.
55. J. Jiang, Z. Lv, Y. Gu et al., "Adult rat mesenchymal stem cells differentiate into neuronal-like phenotype and express a variety of neuro-regulatory molecules in vitro," Neuroscience Research, vol. 66, no. 1, pp. 46-52, 2010.
56. Y. S. Levy, M. Bahat-Stroomza, R. Barzilay et al., "Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease," Cytotherapy, vol. 10, no. 4, pp. 340-352, 2008.
57. L.-Y. Yang, T.-H. Huang, and L. Ma, "Bone marrow stromal cells express neural phenotypes in vitro and migrate in brain after transplantation in vivo," Biomedical and Environmental Sciences, vol. 19, no. 5, pp. 329-335, 2006.
58. G. F. Barnabé, T. T. Schwindt, M. E. Calcagnotto et al., "Chemically-induced RAT mesenchymal stem cells adopt molecular properties of neuronal-like cells but do not have basic neuronal functional properties," PLoS ONE, vol. 4, no. 4, article e5222, 2009.
59. J. G. Boyd, R. Doucette, and M. D. Kawaja, "Defining the role of olfactory ensheathing cells in facilitating axon remyelination following damage to the spinal cord," The FASEB Journal, vol. 19, no. 7, pp. 694-703, 2005.
60. H. Huang, L. Chen, H. Wang et al., "Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI," Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 20, no. 4, pp. 439-443, 2006.
61. H. Huang, H. Wang, L. Chen et al., "Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury," Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 20, no. 4, pp. 434-438, 2006.
62. H. Huang, L. Chen, H. Xi et al., "Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients," Zhongguo Xiu Fu Chong JianWai Ke Za Zhi, vol. 23, no. 1, pp. 14-20, 2009.
63. B. H. Dobkin, A. Curt, and J. Guest, "Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury," Neurorehabilitation and Neural Repair, vol. 20, no. 1, pp. 5-13, 2006.
64. I. D. Duncan, A. J. Aguayo, R. P. Bunge, and P. M. Wood, "Transplantation of rat Schwann cells grown in tissue culture into the mouse spinal cord," Journal of the Neurological Sciences, vol. 49, no. 2, pp. 241-252, 1981.
65. V. H. Perry, M. C. Brown, and S. Gordon, "The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration," Journal of Experimental Medicine, vol. 165, no. 4, pp. 1218-1223, 1987.
66. B. K. Kwon, E. B. Okon, E. Tsai et al., "A grading system to objectively evaluate the strength of preclinical data of acute neuroprotective therapies for clinical translation in spinal cord injury," Journal of Neurotrauma. In press.
67. R. Talac, J. A. Friedman, M. J. Moore et al., "Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies," Biomaterials, vol. 25, no. 9, pp. 1505-1510, 2004.
68. Q. Han, W. Sun, H. Lin et al., "Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats," Tissue Engineering Part A, vol. 15, no. 10, pp. 2927-2935, 2009.
69. P. J. Johnson, S. R. Parker, and S. E. Sakiyama-Elbert, "Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury," Biotechnology and Bioengineering, vol. 104, no. 6, pp. 1207-1214, 2009.
70. E. Syková, P. Jendelová, L. Urdzíková, P. Lesný, and A. Hejčl, "Bone marrow stem cells and polymer hydrogels- two strategies for spinal cord injury repair," Cellular and Molecular Neurobiology, vol. 26, no. 7-8, pp. 1113-1129, 2006.
71. Y. D. Teng, E. B. Lavik, X. Qu et al., "Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 3024-3029, 2002.
72. H. Okano, Y. Ogawa, M. Nakamura, S. Kaneko, A. Iwanami, and Y. Toyama, "Transplantation of neural stem cells into the spinal cord after injury," Seminars in Cell and Developmental Biology, vol. 14, no. 3, pp. 191-198, 2003.
73. S. Okada, K. Ishii, J. Yamane et al., "In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury," The FASEB Journal, vol. 19, no. 13, pp. 1839-1841, 2005.
74. D. Y. Wong, S. J. Hollister, P. H. Krebsbach, and C. Nosrat, "Poly(ε-caprolactone) and poly (L-lactic-co-glycolic acid) degradable polymer sponges attenuate astrocyte response and lesion growth in acute traumatic brain injury," Tissue Engineering, vol. 13, no. 10, pp. 2515-2523, 2007.
75. C. D. Pritchard, J. R. Slotkin, D. Yu et al., "Establishing a model spinal cord injury in the African green monkey for the preclinical evaluation of biodegradable polymer scaffolds seeded with human neural stemcells," Journal of Neuroscience Methods, vol. 188, no. 2, pp. 258-269, 2010.
76. B. K. Chen, A. M. Knight, G. C. W. de Ruiter et al., "Axon regeneration through scaffold into distal spinal cord after transection," Journal of Neurotrauma, vol. 26, no. 10, pp. 1759-1771, 2009.
77. K. Fouad, I. Klusman, and M. E. Schwab, "Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1," European Journal of Neuroscience, vol. 20, no. 9, pp. 2479-2482, 2004.
78. V. J. Tom and J. D. Houlé, "Intraspinal microinjection of chondroitinase ABC following injury promotes axonal regeneration out of a peripheral nerve graft bridge," Experimental Neurology, vol. 211, no. 1, pp. 315-319, 2008.
79. J. Sharp, J. Frame, M. Siegenthaler, G. Nistor, and H. S. Keirstead, "Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury," StemCells, vol. 28, no. 1, pp. 152-163, 2010.
80. V. Sahni and J. A. Kessler, "Stem cell therapies for spinal cord injury," Nature Reviews Neurology, vol. 6, no. 7, pp. 363-372, 2010.
81. A. I. Teixeira, J. K. Duckworth, and O. Hermanson, "Getting the right stuff: controlling neural stem cell state and fate in vivo and in vitro with biomaterials," Cell Research, vol. 17, no. 1, pp. 56-61, 2007.
82. D. M. Choumerianou, H. Dimitriou, and M. Kalmanti, "Stem cells: promises versus limitations," Tissue Engineering Part B, vol. 14, no. 1, pp. 53-60, 2008.
83. J. S. Draper, K. Smith, P. Gokhale et al., "Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells," Nature Biotechnology, vol. 22, no. 1, pp. 53-54, 2004.
84. B. Lo and L. Parham, "Ethical issues in stem cell research," Endocrine Reviews, vol. 30, no. 3, pp. 204-213, 2009.
85. J. Alper, "Geron gets green light for human trial of ES cellderived product," Nature Biotechnology, vol. 27, no. 3, pp. 213-214, 2009.
86. K. Jin and V. Galvan, "Endogenous neural stem cells in the adult brain," Journal of Neuroimmune Pharmacology, vol. 2, no. 3, pp. 236-242, 2007.
87. A. Iwanami, S. Kaneko, M. Nakamura et al., "Transplantation of human neural stem cells for spinal cord injury in primates," Journal of Neuroscience Research, vol. 80, no. 2, pp. 182-190, 2005.
88. A. M. Parr, I. Kulbatski, T. Zahir et al., "Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury," Neuroscience, vol. 155, no. 3, pp. 760-770, 2008.
89. M. Nakamura, H. Okano, Y. Toyama, H. N. Dai, T. P. Finn, and B. S. Bregman, "Transplantation of embryonic spinal cord-derived neurospheres support growth of supraspinal projections and functional recovery after spinal cord injury in the neonatal rat," Journal of Neuroscience Research, vol. 81, no. 4, pp. 457-468, 2005.
90. C. P. Hofstetter, N. A. V. Holmström, J. A. Lilja et al., "Allodynia limits the usefulness of intraspinal neural stemcell grafts; directed differentiation improves outcome," Nature Neuroscience, vol. 8, no. 3, pp. 346-353, 2005.
91. K. Takahashi and S. Yamanaka, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors," Cell, vol. 126, no. 4, pp. 663-676, 2006.
92. S. Yamanaka, "A fresh look at iPS cells," Cell, vol. 137, no. 1, pp. 13-17, 2009.
93. S. J. Chen, C. M. Chang, S. K. Tsai et al., "Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue," Stem Cells and Development, vol. 19, no. 11, pp. 1757-1767, 2010.
94. H. Kawai, T. Yamashita, Y. Ohta et al., "Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain," Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 8, pp. 1487-1493, 2010.
95. R. P.F. Salewski, E. Eftekharpour, and M. G. Fehlings, "Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?" Journal of Cellular Physiology, vol. 222, no. 3, pp. 515-521, 2010.
96. H. Zhou, S. Wu, J. Y. Joo et al., "Generation of induced pluripotent stemcells using recombinant proteins," Cell Stem Cell, vol. 4, no. 5, pp. 381-384, 2009.
97. Y. Shi, C. Desponts, J. T. Do, H. S. Hahm, H. R. Schö, and S. Ding, "Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds," Cell Stem Cell, vol. 3, no. 5, pp. 568-574, 2008.
98. K. Kaji, K. Norrby, A. Paca, M. Mileikovsky, P. Mohseni, and K. Woltjen, "Virus-free induction of pluripotency and subsequent excision of reprogramming factors," Nature, vol. 458, no. 7239, pp. 771-775, 2009.
99. A. Giorgetti, N. Montserrat, I. Rodriguez-Piza, C. Azqueta, A. Veiga, and J. C. Izpisüa Belmonte, "Generation of induced pluripotent stemcells from human cord blood cells with only two factors:Oct4 and Sox2," Nature Protocols, vol. 5, no. 4, pp. 811-820, 2010.
100. H.-X. Zhao, Y. Li, H.-F. Jin et al., "Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG," Differentiation, vol. 80, no. 2-3, pp. 123-129, 2010.
101. Y. H. Ma, Y. Zhang, L. Cao et al., "Effect of neurotrophin-3 genetically modified olfactory ensheathing cells transplantation on spinal cord injury," Cell Transplantation, vol. 19, no. 2, pp. 167-177, 2010.
102. G. E. Rooney, S. S. McMahon, T. Ritter et al., "Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells," Tissue Engineering Part A, vol. 15, no. 10, pp. 3049-3059, 2009.
103. H. S. Sharma, "A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury," Annals of the New York Academy of Sciences, vol. 1122, pp. 95-111, 2007.
104. M. C. Jimenez Hamann, C. H. Tator, and M. S. Shoichet, "Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord," Experimental Neurology, vol. 194, no. 1, pp. 106-119, 2005.
105. Q. Cao, Q. He, Y. Wang et al., "Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury," Journal of Neuroscience, vol. 30, no. 8, pp. 2989-3001, 2010.
106. A. C. Conta and D. J. Stelzner, "Immunomodulatory effect of the purine nucleoside inosine following spinal cord contusion injury in rat," Spinal Cord, vol. 46, no. 1, pp. 39-44, 2008.
107. L. Zhang, Z. Ma, G. M. Smith et al., "GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons," GLIA, vol. 57, no. 11, pp. 1178-1191, 2009.
108. V. J. Tom, R. Kadakia, L. Santi, and J. D. Houlé"Administration of chondroitinase ABC rostral or caudal to a spinal cord injury site promotes anatomical but not functional plasticity," Journal of Neurotrauma, vol. 26, no. 12, pp. 2323-2333, 2009.
109. T. Ikegami, M. Nakamura, J. Yamane et al., "Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growthassociated protein-43-positive fibers after rat spinal cord injury," European Journal of Neuroscience, vol. 22, no. 12, pp. 3036-3046, 2005.
110. L. A. Robak, K. Venkatesh, H. Lee et al., "Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNSmyelin inhibition," Journal of Neuroscience, vol. 29, no. 18, pp. 5768-5783, 2009.
111. M. Douglas Baumann, J. W. Austin, M. G. Fehlings, and M. S. Shoichet, "A quantitative ELISA for bioactive anti-Nogo- A, a promising regenerative molecule for spinal cord injury repair," Methods, vol. 47, no. 2, pp. 104-108, 2009.
112. W. B.J. Cafferty, P. Duffy, E. Huebner, and S. M. Strittmatter, "MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma," Journal of Neuroscience, vol. 30, no. 20, pp. 6825-6837, 2010.
113. E. J. Bradbury, L. D. F. Moon, R. J. Popat et al., "Chondroitinase ABC promotes functional recovery after spinal cord injury," Nature, vol. 416, no. 6881, pp. 636-640, 2002.
114. S. Li, B. P. Liu, S. Budel et al., "Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury," Journal of Neuroscience, vol. 24, no. 46, pp. 10511-10520, 2004.
115. P. Yu, L. Huang, J. Zou et al., "Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats," Neurobiology of Disease, vol. 32, no. 3, pp. 535-542, 2008.
116. A. Mountney, M. R. Zahner, I. Lorenzini, M. Oudega, L. P. Schramm, and R. L. Schnaar, "Sialidase enhances recovery from spinal cord contusion injury," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 25, pp. 11561-11566, 2010.
117. S. A. Chvatal, Y.-T. Kim, A. M. Bratt-Leal, H. Lee, and R. V. Bellamkonda, "Spatial distribution and acute antiinflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord," Biomaterials, vol. 29, no. 12, pp. 1967-1975, 2008.
118. P. D. Storer, D. Dolbeare, and J. D. Houle, "Treatment of chronically injured spinal cord with neurotrophic factors stimulates βII-tubulin and GAP-43 expression in rubrospinal tract neurons," Journal of Neuroscience Research, vol. 74, no. 4, pp. 502-511, 2003.
119. S. H. Min, S. H. Lee, H. Shim et al., "Development of complete thoracic spinal cord transection model in rats for delayed transplantation of stem cells," Spine. In press.
120. H. Nomura, T. Zahir, H. Kim et al., "Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection," Tissue Engineering Part A, vol. 14, no. 5, pp. 649-665, 2008.
121. J. Cai, K. S. Ziemba, G. M. Smith, and Y. Jin, "Evaluation of cellular organization and axonal regeneration through linear PLA foam implants in acute and chronic spinal cord injury," Journal of BiomedicalMaterials Research Part A, vol. 83, no. 2, pp. 512-520, 2007.
122. M. Merle, A. L. Dellon, J. N. Campbell, and P. S. Chang, "Complications from silicon-polymer intubulation of nerves," Microsurgery, vol. 10, no. 2, pp. 130-133, 1989.
123. Y. Zhong and R. V. Bellamkonda, "Biomaterials for the central nervous system," Journal of the Royal Society Interface, vol. 5, no. 26, pp. 957-975, 2008.
124. G. Orive, E. Anitua, J. L. Pedraz, and D. F. Emerich, "Biomaterials for promoting brain protection, repair and regeneration," Nature Reviews Neuroscience, vol. 10, no. 9, pp. 682-692, 2009.
125. S. J. Taylor and S. E. Sakiyama-Elbert, "Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model," Journal of Controlled Release, vol. 116, no. 2, pp. 204-210, 2006.
126. G. E. Rooney, C. Moran, S. S. McMahon et al., "Genemodified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrate," Tissue Engineering Part A, vol. 14, no. 5, pp. 681-690, 2008.
127. C. E. Kang, P. C. Poon, C. H. Tator, and M. S. Shoichet, "A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair," Tissue Engineering Part A, vol. 15, no. 3, pp. 595-604, 2009.
128. Y.-C. Wang, Y.-T. Wu, H.-Y. Huang et al., "Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury," Biomaterials, vol. 29, no. 34, pp. 4546-4553, 2008.
129. M. Takenaga, T. Ishihara, Y. Ohta et al., "Nano PGE1 promoted the recovery from spinal cord injury-induced motor dysfunction through its accumulation and sustained release," Journal of Controlled Release. In press.
130. S. Das, A. K. Mandal, A. Ghosh, S. Panda, N. Das, and S. Sarkar, "Nanoparticulated quercetin in combating age related cerebral oxidative injury," Current Aging Science, vol. 1, no. 3, pp. 169-174, 2008.
131. E. C. Tsai, P. D. Dalton, M. S. Shoichet, and C. H. Tator, "Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection," Biomaterials, vol. 27, no. 3, pp. 519-533, 2006.
132. H. E. Olson, G. E. Rooney, L. Gross et al., "Neural stem celland schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord," Tissue Engineering Part A, vol. 15, no. 7, pp. 1797-1805, 2009.
133. C. M. Patist, M. B. Mulder, S. E. Gautier, V. Maquet, R. Jérôme, and M. Oudega, "Freeze-dried poly(D,L-lactic acid) macroporous guidance scaffolds impregnated with brainderived neurotrophic factor in the transected adult rat thoracic spinal cord," Biomaterials, vol. 25, no. 9, pp. 1569-1582, 2004.
134. A. Hurtado, L.D. F. Moon, V. Maquet, B. Blits, R. Jérôme, and M. Oudega, "Poly (D,L-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord," Biomaterials, vol. 27, no. 3, pp. 430-442, 2006.
135. N. Zhang, C. Zhang, and X. Wen, "Fabrication of semipermeable hollow fiber membranes with highly aligned texture for nerve guidance," Journal of Biomedical Materials Research Part A, vol. 75, no. 4, pp. 941-949, 2005.
136. X. Wen and P. A. Tresco, "Effect of filament diameter and extracellular matrix molecule precoating on neurite outgrowth and Schwann cell behavior on multifilament entubulation bridging device in vitro," Journal of Biomedical Materials Research Part A, vol. 76, no. 3, pp. 626-637, 2006.
137. L. Ghasemi-Mobarakeh, M. P. Prabhakaran, M. Morshed, M.-H. Nasr-Esfahani, and S. Ramakrishna, "Electrospun poly(ε-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering," Biomaterials, vol. 29, no. 34, pp. 4532-4539, 2008.
138. J. Mehrholz, J. Kugler, and M. Pohl, "Locomotor training for walking after spinal cord injury," Spine, vol. 33, no. 21, pp. E768-E777, 2008.
139. A. Foret, R. Quertainmont, O. Botman et al., "Stem cells in the adult rat spinal cord: plasticity after injury and treadmill training exercise," Journal of Neurochemistry, vol. 112, no. 3, pp. 762-772, 2010.
140. T. Kao, J. S. Shumsky, M. Murray, and K. A. Moxon, "Exercise induces cortical plasticity after neonatal spinal cord injury in the rat," Journal of Neuroscience, vol. 29, no. 23, pp. 7549-7557, 2009.
141. M. MacIas, A. Dwornik, E. Ziemlinska et al., "Locomotor exercise alters expression of pro-brain-derived neurotrophic factor, brain-derived neurotrophic factor and its receptor TrkB in the spinal cord of adult rats," European Journal of Neuroscience, vol. 25, no. 8, pp. 2425-2444, 2007.
142. M. Macias, D. Nowicka, A. Czupryn et al., "Exercise-induced motor improvement after complete spinal cord transection and its relation to expression of brain-derived neurotrophic factor and presynaptic markers," BMC Neuroscience, vol. 10, article 144, 2009.
143. T. Endo, T. Ajiki, H. Inoue et al., "Early exercise in spinal cord injured rats induces allodynia through TrkB signaling," Biochemical and Biophysical Research Communications, vol. 381, no. 3, pp. 339-344, 2009.
144. I. C. Maier, R. M. Ichiyama, G. Courtine et al., "Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury," Brain, vol. 132, no. 6, pp. 1426-1440, 2009.
145. M. B. Bunge, "Novel combination strategies to repair the injured mammalian spinal cord," Journal of Spinal Cord Medicine, vol. 31, no. 3, pp. 262-269, 2008.
146. G. Wang, Q. Ao, K. Gong, Y. Gong, and X. Zhang, "Synergistic effect of neural stem cells and olfactory ensheathing cells on repair of adult rat spinal cord injury," Cell Transplantation. In press.
147. T. Amemori, P. Jendelová, K. Růžičková, D. Arboleda, and E. Syková, "Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat," Cytotherapy, vol. 12, no. 2, pp. 212-225, 2010.
148. Y. Chiba, S. Kuroda, H. Shichinohe et al., "Synergistic effects of bone marrow stromal cells and a Rho kinase (ROCK) inhibitor, Fasudil on axon regeneration in rat spinal cord injury," Neuropathology, vol. 30, no. 3, pp. 241-250, 2010.
149. T. Furuya, M. Hashimoto, M. Koda et al., "Treatment of rat spinal cord injury with a Rho-kinase inhibitor and bone marrow stromal cell transplantation," Brain Research, vol. 1295, pp. 192-202, 2009.
150. P. J. Johnson, A. Tatara, A. Shiu, and S. E. Sakiyama- Elbert, "Controlled release of neurotrophin-3 and plateletderived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI," Cell Transplantation, vol. 19, no. 1, pp. 89-101, 2010.
151. F. Bretzner, J. Liu, E. Currie, A. J. Roskams, and W. Tetzlaff, "Undesired effects of a combinatorial treatment for spinal cord injury-transplantation of olfactory ensheathing cells and BDNF infusion to the red nucleus," European Journal of Neuroscience, vol. 28, no. 9, pp. 1795-1807, 2008.
152. H. Lee, R. J. McKeon, and R. V. Bellamkonda, "Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3340-3345, 2010.
153. F. Bai, H. Peng, J. D. Etlinger, and R. J. Zeman, "Partial functional recovery after complete spinal cord transection by combined chondroitinase and clenbuterol treatment," Pflugers Archiv European Journal of Physiology, vol. 460, no. 3, pp. 657-666, 2010.
154. I. Wu, H. Yang, Z. Qiu, Q. Zhang, T. Ding, and D. Geng, "Effect of combined treatment with methylprednisolone and Nogo-A monoclonal antibody after rat spinal cord injury," Journal of International Medical Research, vol. 38, no. 2, pp. 570-582, 2010.
155. L. C. Gleeson, K. J. Ryan, T. W. Griffin, T. J. Connor, and A. Harkin, "The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity," Brain, Behavior, and Immunity, vol. 24, no. 8, pp. 1354-1361, 2010.